首页> 外国专利> HCV RNA-polymerase NS5B nucleoside inhibitor, 2-{(2R, 3S, 5R) -5- (4-amino-2-oxo-2H-pyrimidin-1-yl) -3-hydroxy-tetrahydro-furan -2-ylmethoxy -phenoxy-phosphorylamino} -alkyl propionate, process for its preparation and use

HCV RNA-polymerase NS5B nucleoside inhibitor, 2-{(2R, 3S, 5R) -5- (4-amino-2-oxo-2H-pyrimidin-1-yl) -3-hydroxy-tetrahydro-furan -2-ylmethoxy -phenoxy-phosphorylamino} -alkyl propionate, process for its preparation and use

机译:HCV RNA聚合酶NS5B核苷抑制剂,2-{[((2R,3S,5R))-5-(4-氨基-2-氧代-2H-嘧啶-1-基)-3-羟基-四氢呋喃-2-丙氧基[甲氧基]-苯氧基-磷酰氨基}-烷基酯,其制备方法和用途

摘要

Compounds of general formula 1 or stereoisomers thereof, pharmaceutically acceptable salts and / or hydrates, solvates or crystalline forms thereof: wherein R1 is C1-C4 alkyl; R2 and R3 is fluoro, or R2 is fluoro, and R3 is methyl; R4 and R5 are H, or R4 is C1-C6 acyl, and R5 is hydrogen, or R4 Is hydrogen and R5 is C1-C6 acyl; R4 is an optionally substituted aminoacyl and R5 is hydrogen or R4 is hydrogen and R5 is optionally Optionally substituted aminoacyl; R6 is hydrogen, methyl, methoxy or halogen;
机译:通式1的化合物或其立体异构体,其药学上可接受的盐和/或水合物,溶剂化物或晶体形式:其中R1为C1-C4烷基; R2和R3为氟,或R2为氟,且R3为甲基; R4和R5为H,或R4为C1-C6酰基,R5为氢,或R4为氢且R5为C1-C6酰基。 R4为任选取代的氨基酰基,R5为氢或R4为氢且R5为任选取代的氨基酰基; R6是氢,甲基,甲氧基或卤素;

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号